Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling

eLife

Volumn 5, Issue JANUARY2016, 2016, Pages

  Hattermann, Kirsten ^a   Gebhardt, Henrike ^a   Krossa, Sebastian ^a   Ludwig, Andreas ^b   Lucius, Ralph ^a   Held Feindt, Janka ^c   Mentlein, Rolf ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL16 CHEMOKINE; FRACTALKINE; TUMOR NECROSIS FACTOR; ALPHA CHEMOKINE; CX3CL1 PROTEIN, HUMAN; CXCL16 PROTEIN, HUMAN; PROTEIN BINDING; SCAVENGER RECEPTOR;

APOPTOSIS; ARTICLE; BRAIN TUMOR; BREAST CARCINOMA; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIMERIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INVERSE SIGNALING; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; DRUG EFFECTS; METABOLISM; PROTEIN MULTIMERIZATION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CX3CL1; CHEMOKINES, CXC; HUMANS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION;

EID: 84956876503     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10820     Document Type: Article

References (51)

1. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen K-J, Saftig P, Rose-John S, Ludwig A. 2004. The transmembrane CXC-chemokine ligand 16 is induced by IFN-and TNF-and shed by the activity of the disintegrin-like metalloproteinase ADAM10. The Journal of Immunology 172:6362-6372. doi: 10.4049/jimmunol.172.10.6362.
2. Amanchy R, Kandasamy K, Mathivanan S, Periaswamy B, Reddy R, Yoon WH, Joore J, Beer MA, Cope L, Pandey A. 2011. Identification of novel phosphorylation motifs through an integrative computational and experimental analysis of the human phosphoproteome. Journal of Proteomics & Bioinformatics 4:22-35. doi: 10.4172/jpb.1000163.
3. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644. doi: 10.1038/385640a0.
4. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Research 38:3751-3757.
5. Daar IO. 2012. Non-SH2/PDZ reverse signaling by ephrins. Seminars in Cell & Developmental Biology 23:65-74. doi: 10.1016/j.semcdb.2011.10.012.
6. Eissner G, Kolch W, Scheurich P. 2004. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine & Growth Factor Reviews 15:353-366. doi: 10.1016/j.cytogfr.2004.03.011.
7. Ferran C, Dautry F, Mérite S, Sheehan K, Schreiber R, Grau G, Bach JF, Chatenoud L. 1994. Anti-tumor necrosis factor modulates anti-CD3-triggered t cell cytokine gene expression in vivo. The Journal of Clinical Investigation 93:2189-2196. doi: 10.1172/JCI117215.
8. Fodstad ØYstein, Aamdal S, McMenamin M, Nesland JM, Pihl A. 1988. A new experimental metastasis model in athymic nude mice, the human malignant melanoma lox. International Journal of Cancer 41:442-449. doi: 10.1002/ijc.2910410322.
9. Fogh J, Trempe G. 1957. New Human Tumor Cell Lines. In: Human Tumor Cells in Vitro. New York: Plenum Publishing Crop; 115-159.
10. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L. 2000. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. Journal of Leukocyte Biology 67:577-584.
11. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. 2001. Tumor necrosis factor-alpha-converting enzyme (aDAM17) mediates the cleavage and shedding of fractalkine (cX3CL1). The Journal of Biological Chemistry 276:37993-38001. doi: 10.1074/jbc.M106434200.
12. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. Journal of the National Cancer Institute 51:1417-1423.
13. Griffin CA, Baylin SB. 1985. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Research 45:272-275.
14. Hattermann K, Held-Feindt J, Lucius R, Müerköster SS, Penfold ME, Schall TJ, Mentlein R. 2010. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Research 70:3299-3308. doi: 10.1158/0008-5472.CAN-09-3642.
15. Hattermann K, Held-Feindt J, Ludwig A, Mentlein R. 2013. The CXCL16-CXCR6 chemokine axis in glial tumors. Journal of Neuroimmunology 260:47-54. doi: 10.1016/j.jneuroim.2013.04.006.
16. Hattermann K, Ludwig A, Gieselmann V, Held-Feindt J, Mentlein R. 2008. The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Molecular and Cellular Neurosciences 39: 133-141. doi: 10.1016/j.mcn.2008.03.009.
17. Held-Feindt J, Hattermann K, Müerköster SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM, Mentlein R. 2010. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (gIMs). Experimental Cell Research 316:1553-1566. doi: 10.1016/j.yexcr.2010.02.018.
18. Held-Feindt J, Rehmke B, Mentlein R, Hattermann K, Knerlich F, Hugo HH, Ludwig A, Mehdorn HM. 2008. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Glia 56: 764-774. doi: 10.1002/glia.20651.
19. Hermand P, Pincet F, Carvalho S, Ansanay H, Trinquet E, Daoudi M, Combadière C, Deterre P. 2008. Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. role of the transmembrane domain. The Journal of Biological Chemistry 283:30225-30234. doi: 10.1074/jbc.M802638200.
20. Hoover DM, Mizoue LS, Handel TM, Lubkowski J. 2000. The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement. The Journal of Biological Chemistry 275:23187-23193. doi: 10.1074/jbc.M002584200.
21. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195. doi: 10.1182/blood-2002-12-3775.
22. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-530. doi: 10.1016/S0092-8674(00)80438-9.
23. Isozaki T, Otsuka K, Sato M, Takahashi R, Wakabayashi K, Yajima N, Miwa Y, Kasama T. 2011. Synergistic induction of CX3CL1 by interleukin-1 and interferon-g in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathwayss. Translational Research 157:64-70. doi: 10.1016/j.trsl.2010.11.007.
24. Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. 2005. Adam meets eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123:291-304. doi: 10.1016/j.cell.2005.08.014.
25. Kennelly PJ, Krebs EG. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. The Journal of Biological Chemistry 266:15555-15558.
26. Klein R. 2009. Bidirectional modulation of synaptic functions by eph/ephrin signaling. Nature Neuroscience 12: 15-20. doi: 10.1038/nn.2231.
27. Lettau M, Paulsen M, Schmidt H, Janssen O. 2011. Insights into the molecular regulation of FasL (cD178) biology. European Journal of Cell Biology 90:456-466. doi: 10.1016/j.ejcb.2010.10.006.
28. Ludwig A, Schulte A, Schnack C, Hundhausen C, Reiss K, Brodway N, Held-Feindt J, Mentlein R. 2005. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. Journal of Neurochemistry 93:1293-1303. doi: 10.1111/j.1471-4159.2005.03123.x.
29. Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L. 2013. Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PloS One 8: e68176. doi: 10.1371/journal.pone.0068176.
30. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor bonzo. Nature Immunology 1:298-304. doi: 10.1038/79738.
31. Matsuo K, Otaki N. 2012. Bone cell interactions through eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adhesion & Migration 6:148-156. doi: 10.4161/cam.20888.
32. Neely GG, Epelman S, Ma LL, Colarusso P, Howlett CJ, Amankwah EK, McIntyre AC, Robbins SM, Mody CH. 2004. Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. The Journal of Immunology 172:4225-4234. doi: 10.4049/jimmunol.172.7.4225.
33. Odemis V, Lipfert J, Kraft R, Hajek P, Abraham G, Hattermann K, Mentlein R, Engele J. 2012. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. Glia 60:372-381. doi: 10.1002/glia.22271.
34. Ostuni MA, Guellec J, Hermand P, Durand P, Combadière C, Pincet F, Deterre P. 2014. CX3CL1, a chemokine finely tuned to adhesion: critical roles of the stalk glycosylation and the membrane domain. Biology Open 3: 1173-1182. doi: 10.1242/bio.20149845.
35. Ponten JAN, Macintyre EH. 1968. Long term culture of normal and neoplastic human glia. Acta Pathologica Microbiologica Scandinavica 74:465-486. doi: 10.1111/j.1699-0463.1968.tb03502.x.
36. Pruessmeyer J, Ludwig A. 2009. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Seminars in Cell & Developmental Biology 20:164-174. doi: 10.1016/j.semcdb.2008.09.005.
37. Reiss K, Saftig P. 2009. The “a disintegrin and metalloprotease” (aDAM) family of sheddases: physiological and cellular functions. Seminars in Cell & Developmental Biology 20:126-137. doi: 10.1016/j.semcdb.2008.11.002.
38. Roscic-Mrkic B, Fischer M, Leemann C, Manrique A, Gordon CJ, Moore JP, Proudfoot AE, Trkola A. 2005. RANTES (cCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102:1169-1177. doi: 10.1182/blood-2003-02-0488.
39. Schumacher U, Adam E, Zangemeister-Wittkel U, Gossrau R. 1996. Histochemistry of therapeutically relevant enzymes in human tumours transplanted into severe combined immunodeficient (sCID) mice: nitric oxide synthase — associated diaphorase, b-d-glucuronidase and nonspecific alkaline phosphatase. Acta Histochemica 98:381-387. doi: 10.1016/S0065-1281(96)80004-3.
40. Shao Z, Schwarz H. 2011. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. Journal of Leukocyte Biology 89:21-29. doi: 10.1189/jlb.0510315.
41. Soule HD, Vazguez J, Long A, Albert S, Brennan M. 1973. A human cell line from a pleural effusion derived from a breast carcinoma. Journal of the National Cancer Institute 51:1409-1416.
42. Stein GH. 1979. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. Journal of Cellular Physiology 99:43-54. doi: 10.1002/jcp.1040990107.
43. Sun M, Fink PJ. 2007. A new class of reverse signaling costimulators belongs to the TNF family. The Journal of Immunology 179:4307-4312. doi: 10.4049/jimmunol.179.7.4307.
44. Thies A, Mauer S, Fodstad O, Schumacher U. 2007. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. British Journal of Cancer 96:609-616. doi: 10.1038/sj.bjc.6603594.
45. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Research 42:1530-1536.
46. Watts AD, Hunt NH, Wanigasekara Y, Bloomfield G, Wallach D, Roufogalis BD, Chaudhri G. 1999. A casein kinase i motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ’reverse signalling’. The EMBO Journal 18:2119-2126. doi: 10.1093/emboj/18.8.2119.
47. Westermark B, Pontén J, Hugosson R. 1973. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathologica Microbiologica Scandinavica Section a Pathology 81A:791-805. doi: 10.1111/j.1699-0463.1973.tb03573.x.
48. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, Briskin M. 2001. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. The Journal of Immunology 166:5145-5154. doi: 10.4049/jimmunol.166.8.5145.
49. Yamaguchi M, Zhu S, Zhang S, Wu D, Moore TM, Snyder JP, Shoji M. 2014. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis. Cell and Tissue Research 357:245-266. doi: 10.1007/s00441-014-1846-4.
50. Yu L, Zhou Y, Cheng S, Rao Y. 2010. Plexin a-semaphorin-1a reverse signaling regulates photoreceptor axon guidance in drosophila. Journal of Neuroscience 30:12151-12156. doi: 10.1523/JNEUROSCI.1494-10.2010.
51. Zhou Y, Gunput RA, Pasterkamp RJ. 2008. Semaphorin signaling: progress made and promises ahead. Trends in Biochemical Sciences 33:161-170. doi: 10.1016/j.tibs.2008.01.006.